Thompson Siegel & Walmsley’s Acadia Healthcare ACHC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15	Closed	–	–	642
2019 Q4	$0	Buy	+15	New	+$470	﹤0.01%	785
2018 Q4	–	Sell	-467	Closed	-$16K	–	743
2018 Q3	$16K	Hold	467	–	–	﹤0.01%	630
2018 Q2	$19K	Hold	467	–	–	﹤0.01%	634
2018 Q1	$18K	Hold	467	–	–	﹤0.01%	630
2017 Q4	$15K	Hold	467	–	–	﹤0.01%	675
2017 Q3	$22K	Hold	467	–	–	﹤0.01%	636
2017 Q2	$23K	Hold	467	–	–	﹤0.01%	632
2017 Q1	$20K	Sell	467 -74	-14%	-$3K	﹤0.01%	642
2016 Q4	$18K	Hold	541	–	–	﹤0.01%	597
2016 Q3	$27K	Hold	541	–	–	﹤0.01%	541
2016 Q2	$30K	Buy	+541	New	+$31.6K	﹤0.01%	510
2013 Q4	–	Sell	-397,550	Closed	-$15.7M	–	639
2013 Q3	$15.7M	Sell	397,550 -202,165	-34%	-$7.5M	0.34%	130
2013 Q2	$19.8M	Buy	+599,715	New	+$19.5M	0.43%	87

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PCP

P2 Capital Partners New York $246M AUM 17.67% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thompson Siegel & Walmsley's ACHC Position: Q1 2020 in Review

Thompson Siegel & Walmsley sold out of Acadia Healthcare (ACHC) in Q1 2020, closing a stake of 15 shares.

Thompson Siegel & Walmsley first reported a position in ACHC in Q2 2013 and held it in 13 quarters. The position peaked at $19.8M in Q2 2013. 218 funds tracked by Wall St. Rank hold ACHC as of Q1 2020.

Thompson Siegel & Walmsley reported no remaining Acadia Healthcare position as of Q1 2020 after selling out during the quarter.
Thompson Siegel & Walmsley sold 15 Acadia Healthcare shares in Q1 2020.
Thompson Siegel & Walmsley first reported a position in Acadia Healthcare in Q2 2013 and held it in 13 quarters.
Thompson Siegel & Walmsley's Acadia Healthcare position peaked at $19.8M in Q2 2013.
218 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2020.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2020, filed 12 May 2020.